Literature DB >> 2690184

Recent developments in aromatase inhibition as a potential treatment for oestrogen-dependent breast cancer.

L Banting, P J Nicholls, M A Shaw, H J Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2690184     DOI: 10.1016/s0079-6468(08)70242-x

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN: 0079-6468


× No keyword cloud information.
  12 in total

Review 1.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

2.  Organizational determinants of hospital stay: increasing hospital efficiency.

Authors:  Fernando-Miguel Gamboa-Antiñolo
Journal:  Intern Emerg Med       Date:  2020-04-07       Impact factor: 3.397

Review 3.  Aromatase inhibitors--mechanisms of steroidal inhibitors.

Authors:  R W Brueggemeier
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

4.  Enzymic aromatization of 6-alkyl-substituted androgens, potent competitive and mechanism-based inhibitors of aromatase.

Authors:  M Numazawa; A Yoshimura; M Oshibe
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

5.  Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.

Authors:  Bin Sun; Juma Hoshino; Katie Jermihov; Laura Marler; John M Pezzuto; Andrew D Mesecar; Mark Cushman
Journal:  Bioorg Med Chem       Date:  2010-05-24       Impact factor: 3.641

6.  Docking and 3D-QSAR studies of diverse classes of human aromatase (CYP19) inhibitors.

Authors:  Partha Pratim Roy; Kunal Roy
Journal:  J Mol Model       Date:  2010-03-01       Impact factor: 1.810

Review 7.  Aromatase inhibitors--mechanisms for non-steroidal inhibitors.

Authors:  H V Vanden Bossche; H Moereels; L M Koymans
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  Pharmacophore mapping of flavone derivatives for aromatase inhibition.

Authors:  Shuchi Nagar; Md Ataul Islam; Suvadra Das; Arup Mukherjee; Achintya Saha
Journal:  Mol Divers       Date:  2008-05-28       Impact factor: 2.943

Review 9.  Aromatase inhibitor development for treatment of breast cancer.

Authors:  S Masamura; H Adlercreutz; H Harvey; A Lipton; L M Demers; R J Santen; S J Santner
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

10.  How do care providers evaluate collaboration? - qualitative process evaluation of a cluster-randomized controlled trial of collaborative and stepped care for patients with mental disorders.

Authors:  Kerstin Maehder; Silke Werner; Martin Härter; Olaf von dem Knesebeck; Angelika Weigel; Bernd Löwe; Daniela Heddaeus
Journal:  BMC Psychiatry       Date:  2021-06-08       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.